Altimmune Correlations

ALT Stock

USD 3.58 0.03 0.83%

The current 90-days correlation between Altimmune and DBV Technologies is 0.05 (i.e., Significant diversification). The correlation of Altimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Altimmune Correlation With Market

Average diversification

The correlation between Altimmune and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Altimmune and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Altimmune Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.

Moving together with Altimmune Stock

0.75	DMAC	DiaMedica Therapeutics	Pair Corr
0.78	DNLI	Denali Therapeutics	Pair Corr
0.73	DNTH	Dianthus Therapeutics	Pair Corr
0.71	VCYT	Veracyte	Pair Corr
0.7	DSGN	Design Therapeutics	Pair Corr
0.63	KTTAW	Pasithea Therapeutics	Pair Corr
0.73	VRDN	Viridian Therapeutics	Pair Corr

Moving against Altimmune Stock

0.69	EQ	Equillium Buyout Trend	Pair Corr
0.64	688578	Shanghai Allist Phar	Pair Corr
0.6	PYC	Physiomics Plc	Pair Corr
0.59	DYAI	Dyadic International	Pair Corr
0.57	RAC	Race Oncology	Pair Corr
0.57	VINC	Vincerx Pharma, Common	Pair Corr
0.53	AVH	Avita Medical	Pair Corr
0.52	DRMA	Dermata Therapeutics Buyout Trend	Pair Corr
0.49	VALN	Valneva SE ADR Downward Rally	Pair Corr
0.43	DTIL	Precision BioSciences	Pair Corr
0.41	VIVS	VivoSim Labs, Symbol Change	Pair Corr
0.7	300676	BGI Genomics	Pair Corr
0.66	ALA	Arovella Therapeutics	Pair Corr
0.65	MRVL	Marvel Biosciences Corp	Pair Corr
0.61	ELDN	Eledon Pharmaceuticals	Pair Corr
0.6	ELUT	Elutia Inc	Pair Corr
0.58	RAD	Radiopharm Theranostics	Pair Corr
0.57	EDIT	Editas Medicine	Pair Corr
0.56	ENSC	Ensysce Biosciences	Pair Corr

Related Correlations Analysis

	DBVT	ANNX	KRRO	ENGN	LRMR	AURA	AMRN	ANRO	LBRX	ACIU
DBVT		0.62	-0.32	0.54	0.0	0.09	-0.29	0.64	0.69	0.0	DBVT
ANNX	0.62		-0.77	0.43	-0.2	0.32	-0.66	0.72	0.88	-0.34	ANNX
KRRO	-0.32	-0.77		-0.25	0.58	0.02	0.72	-0.77	-0.62	0.4	KRRO
ENGN	0.54	0.43	-0.25		0.05	0.26	-0.04	0.31	0.46	-0.13	ENGN
LRMR	0.0	-0.2	0.58	0.05		0.3	0.47	-0.46	-0.14	0.33	LRMR
AURA	0.09	0.32	0.02	0.26	0.3		0.01	-0.09	0.36	-0.19	AURA
AMRN	-0.29	-0.66	0.72	-0.04	0.47	0.01		-0.66	-0.65	0.21	AMRN
ANRO	0.64	0.72	-0.77	0.31	-0.46	-0.09	-0.66		0.68	-0.11	ANRO
LBRX	0.69	0.88	-0.62	0.46	-0.14	0.36	-0.65	0.68		-0.32	LBRX
ACIU	0.0	-0.34	0.4	-0.13	0.33	-0.19	0.21	-0.11	-0.32		ACIU
	DBVT	ANNX	KRRO	ENGN	LRMR	AURA	AMRN	ANRO	LBRX	ACIU

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LBRX	+ 0.88	ANNX
ANRO	+ 0.72	ANNX
AMRN	+ 0.72	KRRO
LBRX	+ 0.69	DBVT
LBRX	+ 0.68	ANRO
ANRO	+ 0.64	DBVT

High negative correlations

ANRO	- 0.77	KRRO
KRRO	- 0.77	ANNX
ANRO	- 0.66	AMRN
AMRN	- 0.66	ANNX
LBRX	- 0.65	AMRN
LBRX	- 0.62	KRRO

Risk-Adjusted Indicators

There is a big difference between Altimmune Stock performing well and Altimmune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Altimmune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DBVT	4.47	1.36	0.34	3.50	3.17	(5.86)	16.55	(5.48)	36.36
ANNX	3.95	0.95	0.25	0.96	3.24	(5.02)	10.28	(7.42)	35.10
KRRO	6.24	(1.47)	0.00	(0.16)	0.00	0.00	12.19	(10.00)	91.55
ENGN	6.18	0.71	0.12	0.34	6.36	(8.44)	14.00	(8.90)	61.40
LRMR	4.70	(0.12)	0.00	(0.02)	0.00	0.00	9.59	(8.39)	43.75
AURA	2.50	(0.26)	0.00	(0.03)	0.00	0.00	4.76	(5.91)	17.00
AMRN	2.13	(0.21)	0.00	(0.07)	0.00	0.00	4.18	(4.40)	23.79
ANRO	6.80	2.63	0.41	0.49	5.10	(7.60)	12.56	(8.94)	100.99
LBRX	3.37	0.61	0.17	2.19	2.88	(4.31)	7.62	(5.55)	20.98
ACIU	4.45	0.14	0.05	0.12	5.38	(4.81)	10.46	(10.64)	39.46

Altimmune Corporate Management

Scot Roberts	Chief Scientific Officer	Profile
Richard MBA	Chief Officer	Profile
Andrew MS	Corporate Controller	Profile
Raymond MBA	Chief Officer	Profile
Jos Ochoa	Chief Officer	Profile
MBA MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC